Institutional Manager · CIK 0001909617
QIMING U.S. VENTURES MANAGEMENT, LLC
BELLEVUE, WA · File #028-22101
Latest AUM
$55.6M
Positions
4
Top-10 Concentration
100.0%
Filings
8
Portfolio Value Over Time
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | VENTYX BIOSCIENCES INC | 92332V107 | -412,225 | -$882,162 | $0 |
| EXITED | HILLEVAX INC | 43157M102 | -372,615 | -$741,504 | $0 |
| REDUCE | JASPER THERAPEUTICS INC | 471871202 | 0 | $0 | -$2.9M |
| REDUCE | KEZAR LIFE SCIENCES INC | 49372L209 | 0 | $0 | -$56,352 |
| REDUCE | KORRO BIO INC | 500946108 | 0 | $0 | +$13.0M |
| REDUCE | TOURMALINE BIO INC | 89157D105 | 0 | $0 | +$23.6M |
Filing History
- 13F HOLDINGS REPORTQ/E Sep 20254 pos · $55.6M
- 13F HOLDINGS REPORTQ/E Jun 20256 pos · $23.6M
- 13F HOLDINGS REPORTQ/E Mar 20256 pos · $23.1M
- 13F HOLDINGS REPORTQ/E Dec 20246 pos · $51.1M
- 13F HOLDINGS REPORTQ/E Sep 20246 pos · $51.4M
- 13F HOLDINGS REPORTQ/E Jun 20246 pos · $52.6M
- 13F HOLDINGS REPORTQ/E Mar 20246 pos · $89.7M
- 13F HOLDINGS REPORTQ/E Dec 20237 pos · $75.3M
Top 4 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $35.5M | 63.76% |
| 2 | KORRO BIO INC | 500946108 | 368,085 | $17.6M | 31.68% |
| 3 | JASPER THERAPEUTICS INC | 471871202 | 928,964 | $2.2M | 3.97% |
| 4 | KEZAR LIFE SCIENCES INC | 49372L209 | 82,871 | $323,197 | 0.58% |